Lymphonest Liquid
FDA Label NDC 60986-1004

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Marco Pharma International Llc. for the product Lymphonest (NDC 60986-1004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, otc - keep out of reach of children, suggested use, warnings, dosage & administration, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Coneflower 1x HPUS

Figwort 1x HPUS

Southernwood 3x HPUS

Kerosine 3x HPUS

Cape Aloe 1x HPUS

Hahnemann's soluble mercury 12x HPUS

Timber rattlesnake 10x HPUS

White cedar 10x HPUS

Bushmaster Viper 8x HPUS

Birthwort 6x HPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

For relief of swollen lymph glands; suppressed immune functions.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Suggested Use

30 drops in water 3 times daily. In acute stages, take 50 drops at once followed by 30 drops 4 times daily. Children receive one half or less of the adult amount.

Warnings

If pregnant or breast-feeding, consult a health professional before use. In case of accidental overdose, seek professional assistance or contact a poison control center immediately.

Dosage & Administration

(Read Suggested Use Section)

Inactive Ingredients

Ethyl Alcohol (63% by vol.) and Water

Package Label.Principal Display Panel

Lymphonest.jpg

* Please review the disclaimer below.